Moderna Secures US Government Funding for Bird Flu Vaccine Development
Moderna secures US government funding to develop a vaccine for bird flu amid rising animal infections. With expertise in vaccine development, Moderna is a key player in combatting the virus. The funding will expedite research efforts to bring a vaccine to market, addressing the urgent public health concern of a potential bird flu outbreak.
Moderna’s Combined Flu and Covid Vaccine Shows Promise in Phase-Three Trial
Moderna’s breakthrough two-in-one flu and Covid vaccine shows promising results in phase-three trial, offering convenience and efficiency with fewer injections. Competitors Pfizer and BioNTech are also exploring similar mRNA vaccines, signaling a trend towards comprehensive vaccination solutions. The combined vaccine demonstrated a higher immune response in older populations, with mild side effects reported. Moderna’s ongoing efforts in vaccine development extend to addressing unmet medical needs, highlighting the potential of innovative vaccines in advancing public health.
HHS Advances Plan to Produce 4.8 Million H5N1 Vaccine Doses
HHS is moving forward with a plan to manufacture 4.8 million doses of the H5N1 avian flu vaccine, ensuring uninterrupted production of seasonal flu vaccines. Discussions are ongoing with Pfizer and Moderna for potential involvement in the vaccine development process. A recent surveillance study revealed the prevalence of multidrug-resistant infections in US children, with CRE infections less common than ESBL-E infections.
Global Vaccine Safety Study Identifies Links Between Covid-19 Vaccines and Neurological, Blood, and Heart-Related Conditions
More than 13.5 billion doses of Covid vaccines have been administered globally, with a recent study linking certain vaccines to an increase in neurological, blood, and heart-related conditions. Despite the immense success of Covid vaccination efforts, a small proportion of vaccinated individuals experienced adverse effects, sparking discussions about the overall benefits and potential risks of the vaccines. The study, conducted by the Global Vaccine Data Network, focused on 13 medical conditions considered as ‘adverse events of special interest’ among 99 million vaccinated individuals in eight countries, emphasizing the need for continued monitoring of potential adverse effects as the global vaccination campaign continues.
Experts Debunk Claims that mRNA COVID-19 Vaccines Have Caused More Deaths than Saved Lives
Experts have debunked claims that mRNA COVID-19 vaccines have caused more deaths than saved lives, asserting that the vaccines have actually saved millions of lives. Despite social media posts alleging harm, experts emphasize that the vaccines have undergone rigorous testing and monitoring, with public health experts worldwide attesting to their safety and effectiveness. It is crucial to rely on accurate information and facts when it comes to public health issues, especially in the midst of a global pandemic.
Moderna’s mRNA-1647 Vaccine Shows Promise in Fight Against CMV Virus
Moderna’s mRNA-1647 vaccine shows promise in fighting the CMV virus, offering hope to pregnant women. The vaccine’s safety and efficacy have been confirmed in initial and subsequent research phases, with the final phase expected to conclude within months. Professor Tal Biron-Shental emphasizes the significant harm CMV infection can cause to the fetus and the importance of prevention through vaccination.
First UK Patients Receive Innovative mRNA Therapy for Cancer in Global Trial
First UK patients have received an innovative mRNA therapy for cancer known as mRNA-4359, as part of a global trial. The therapy aims to help the body recognize and fight cancer cells by presenting common markers of tumors to the patient’s immune system. The Mobilize trial, conducted in partnership between Imperial College London and Imperial College Healthcare NHS Trust, is evaluating the safety and potential of the therapy in treating melanoma, lung cancer, and other ‘solid tumor’ cancers. Researchers are hopeful that the therapy may lead to a new treatment option for challenging-to-treat cancers if proven to be safe and effective.
Florida Surgeon General Sparks Controversy with Call to Halt Covid Vaccines
Florida’s surgeon general, Dr. Joseph Ladapo, has sparked controversy by calling for a halt to the use of Covid vaccines, citing debunked concerns about contaminants in the vaccine permanently integrating into human DNA. In a statement released by the Florida…